Cryoport Q4 FY2025: CGT Revenue Rises 29% Cryoport's Q4 FY2025 slides (Mar 26, 2026) show CGT revenue up 29% YoY and expanding margins, a material signal for logistics mix and operating leverage (source: Investing.com).

Cryoport Q4 FY2025: CGT Revenue Rises 29%: Cryoport's Q4 FY2025 slides (Mar 26, 2026) show CGT revenue up 29% YoY and expanding margins, a material signal for logistics mix and operating leverage (source: Investing.com). 👈 Read full analysis #Cryoport #CGT #RevenueGrowth #Logistics #FinancialResults

Cryoport's Remarkable Financial Growth in 2025 Reinforces Leadership in Life Sciences Supply Chain Cryoport reports record financials for FY 2025, highlighting substantial growth and new innovative partnerships in life sciences. A promising outlook for 2026 ahead.

Cryoport's Remarkable Financial Growth in 2025 Reinforces Leadership in Life Sciences Supply Chain #United_States #Nashville #Life_Sciences #CryoPort #BioStorage

Cryoport Launches Innovative MVE Fusion 800 Series, Redefining Cryogenic Storage Solutions Cryoport's new MVE Fusion 800 Series transforms cryogenic storage by offering flexible, high-capacity solutions without the need for continuous liquid nitrogen, ensuring reliable and sustainable usage.

Cryoport Launches Innovative MVE Fusion 800 Series, Redefining Cryogenic Storage Solutions #United_States #Nashville #CryoPort #MVE #Fusion_800

Cryoport's Third Quarter 2025 Results Showcase Strong Growth and Future Prospects Cryoport, Inc. reports a notable 15% revenue growth in Q3 2025, accompanied by strong performance in cell and gene therapy services, projecting an annual revenue of $170-174 million.

Cryoport's Third Quarter 2025 Results Showcase Strong Growth and Future Prospects #USA #Nashville #gene_therapy #Life_Sciences #CryoPort

Cryoport Achieves ISO 21973 Certification, Setting New Standards for Supply Chain in Regenerative Medicine Cryoport, Inc. has achieved the ISO 21973 certification, marking a new milestone in its commitment to safety and traceability for regenerative medicine supply chains.

Cryoport Achieves ISO 21973 Certification, Setting New Standards for Supply Chain in Regenerative Medicine #USA #Nashville #Supply_Chain #regenerative_medicine #CryoPort

MVE Biological Solutions Unveils Cutting-Edge Cryogenic Monitoring Technology for Life Sciences MVE Biological Solutions introduces advanced real-time condition monitoring systems for cryogenic dewars, enhancing life sciences operations. Learn more!

MVE Biological Solutions Unveils Cutting-Edge Cryogenic Monitoring Technology for Life Sciences #United_States #Nashville #CryoPort #MVE #Cryogenic_Monitoring

Cryoport's Q2 2025 Financial Highlights Showcase Robust Growth & Strategic Expansion Cryoport, Inc. reported impressive financial results for Q2 2025, reflecting a 14% revenue increase and strong growth in support of cell and gene therapy services, underscoring its strategic evolution.

Cryoport's Q2 2025 Financial Highlights Showcase Robust Growth & Strategic Expansion #United_States #Nashville #Life_Sciences #Cell_Therapy #CryoPort

Cryoport Unveils Innovative MVE Biological Vapor Shippers for Life Sciences Cryoport, Inc. introduces the next-generation MVE Biological Solutions vapor shippers, enhancing reliability for biological material transport at cryogenic temperatures.

Cryoport Unveils Innovative MVE Biological Vapor Shippers for Life Sciences #USA #Nashville #CryoPort #MVE_Biological #SC_Vapor_Shippers

Cryoport Strategically Partners with DHL After Divesting CRYOPDP Cryoport, Inc. has completed the divestiture of CRYOPDP to DHL Group, initiating a strategic partnership to enhance supply chain solutions in life sciences.

Cryoport Strategically Partners with DHL After Divesting CRYOPDP #United_States #Nashville #CryoPort #DHL_Group #CRYOPDP

Cryoport Reports Strong Q1 2025 Growth and Strategic Partnerships Ahead Cryoport, Inc. shows impressive revenue growth in Q1 2025, driven by strategic partnerships and expanding services in life sciences, setting a positive outlook for the year ahead.

Cryoport Reports Strong Q1 2025 Growth and Strategic Partnerships Ahead #United_States #Nashville #CryoPort #LifeSciences #GeneTherapy

DHL Group Solidifies Position in Health Logistics by Acquiring CRYOPDP DHL Group has acquired CRYOPDP from Cryoport, enhancing its capabilities in health logistics. This acquisition aligns with DHL's strategic goals for the life sciences sector.

DHL Group Solidifies Position in Health Logistics by Acquiring CRYOPDP #Germany #Bonn #CryoPort #DHL_Group #CRYOPDP

DHL strengthens health logistics, acquires CRYOPDP CRYOPDP is a leading specialty courier providing services for clinical trials, biopharma, and cell & gene therapies.

DHL Group and Cryoport, a global provider of supply chain solutions for the life sciences sector, announced that DHL has acquired 100 percent of #CRYOPDP, a leading specialty courier focused on clinical trials, #biopharma, and cell and gene therapies.

#DHLGroup #Cryoport #DHL #clinicaltrials

Cryoport Introduces Next-Gen Cryogenic Freezer Addressing Clinic Needs Cryoport has unveiled the HE 800 C, a pioneering cryogenic freezer designed for fertility clinics and laboratories, enhancing operational efficiency.

Cryoport Introduces Next-Gen Cryogenic Freezer Addressing Clinic Needs #USA #Nashville #CryoPort #HE_800_C #MVE

Cryoport Announces Strong Fourth Quarter and Full Year Financial Results for 2024 Cryoport, Inc. has reported impressive financial results for FY 2024, demonstrating strong growth in cell and gene therapy while enhancing margins.

Cryoport Announces Strong Fourth Quarter and Full Year Financial Results for 2024 #United_States #Nashville #Life_Sciences #CryoPort #CYRX

Moffitt Cancer Center Partners with Cryoport to Enhance Cancer Research Facilities Moffitt Cancer Center collaborates with Cryoport to create advanced biorepository services at its Speros campus, enhancing cancer therapy capabilities.

Moffitt Cancer Center Partners with Cryoport to Enhance Cancer Research Facilities #United_States #Tampa #Moffitt_Cancer_Center #CryoPort #biorepository

Cryoport's MVE Biological Solutions Secures FDA Registration for All Manufacturing Facilities Cryoport's MVE Biological Solutions achieves FDA registration for all manufacturing sites, ensuring high-quality cryogenic storage solutions.

Cryoport's MVE Biological Solutions Secures FDA Registration for All Manufacturing Facilities #United_States #Nashville #CryoPort #MVE_Biological_Solutions #FDA_Registration

Exploring Innovative LNG Solutions at the Microgrid Knowledge Conference CryoPort LNG will highlight its mobile LNG technologies at the Microgrid Knowledge Conference, demonstrating solutions for sustainable energy generation.

Exploring Innovative LNG Solutions at the Microgrid Knowledge Conference #United_States #Dallas #Microgrid #CryoPort #LNG_Solutions